PROGRAM PLANNING AND EVALUATION

基于2003年的NCI审查，并与CUMC和NYPH领导层协商-以及新的 构成外部科学。咨询委员会，HICCC主任概述了重组的战略计划 并扩大中心..该计划包括通过内部晋升重塑HICCC领导层和 为高级别协调委员会招聘人员和建立积极的内部和外部咨询机构。这个计划是 通过招聘临床研究副主任(E. 生物医学信息学副主任(A.Califano博士)和内部晋升 基础研究协理主任(R.Baer博士)、共享资源协理主任 (本杰明·蒂奇科博士)和人口科学副主任(A.Neugut博士)。此外，还有三个 在目前的七个HICCC项目中，都是由新提名的教师领导的。这一重组 领导伴随着对规划和评价的全面改革，以及对 HICCC的内部和外部咨询机构。 HICCC主任有责任和权力确定优先事项和制定新的计划； 提名和保留科学领导者和成员；选择要接收的计划、项目和成员 试点资金；分配HICCC资源；以及组织HICCC作为一个整体，以促进生产力和 科学互动。临床研究副主任协助HICCC主任 完成这些目标并组织HICCC的临床活动。署长的决定如下 根据内部和外部咨询机构的投入。 主要内部咨询机构包括：一)高级领导小组；二)内部咨询 委员会；三)空间委员会；四)成员委员会；和v)共享资源 委员会审议阶段。 外部科学咨询委员会(ESAB)的领导层和组成进行了重组， 目前包括11名成员，代表HICCC研究和管理的主要领域。 要求为伊萨年度会议提供16500美元的资金。

Based on the 2003 NCI review, and in consultation with CUMC and NYPH leadership,- and the newly constituted External Scientific.Advisory Board, the HICCC Director outlined a Strategic Plan to restructure and expand the Center.. The Plan included reshaping HICCC Leadership via internal promotions and recruitments and building active internal and external advisory bodies for the HICCC. This plan was successfully implemented with the recruitment of the Deputy Director for Clinical Research (Dr. E. Gelmann), the Associate Director for Biomedical Informatics (Dr. A. Califano), and the internal promotions of the Associate Director for Basic Research (Dr. R. Baer), the Associate Director for Shared Resources (Dr. Benjamin Tycko), and the Associate Director for Population Science (Dr. A. Neugut). In addition, three of the present seven HICCC Programs are led by newly nominated faculty. This reorganization of leadership has been accompanied by an overhaul of Planning and Evaluation and by the redesign of the HICCC's internal and external advisory bodies. The HICCC Director has the responsibility and authority to set priorities and to develop new Programs; nominate and retain scientific leaders and members; select programs, projects and members to receive pilot funding; allocate HICCC resources;'and organize the HICCC as a whole to promote productivity and scientific interactions. The Deputy Director for Clinical Research assists the HICCC Director in accomplishing these goals and in organizing the HICCC's clinical activities. The Director's decisions are based on input from the internal and external advisory bodies. The main internal advisory bodies include: i) the Senior Leadership Team; ii) the Internal Advisory Committee; iii) the Space Committee; iv) the Membership Committee; . and v) the Shared Resource Committee. The External Scientific Advisory Board (ESAB) has been reorganized in its leadership and composition, currently including 11 members representative of the major areas of HICCC research and administration. Funding in the amount of $16,500 is requested for the annual meeting of the ESAB.